Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

NCT01968720 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemias
Hypertriglyceridemia
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

Interventions

DRUG: CAT-2003
DRUG: Placebo

Sponsor

Catabasis Pharmaceuticals